专题：Dementia and Cognitive Impairment Research

This cluster of papers focuses on the diagnosis, management, and impact of Alzheimer's disease, including its relationship with mild cognitive impairment, dementia, neuroimaging techniques, cognitive decline, biomarkers, aging, and the burden experienced by caregivers. It also explores the role of vascular risk factors and the potential benefits of cognitive training.
最新文献
Alpha‐synuclein co‐pathology in Down syndrome‐associated Alzheimer's disease

article Full Text OpenAlex

18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment

review Full Text OpenAlex

Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study

article Full Text OpenAlex

Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study

article Full Text OpenAlex

Bedtime vs Morning Antihypertensive Medications in Frail Older Adults

article Full Text OpenAlex

A systematic analysis for disease burden, risk factors, and trend projection of Alzheimer’s disease and other dementias in China and globally

article Full Text OpenAlex

2025 Alzheimer's disease facts and figures

article Full Text OpenAlex

Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia

article Full Text OpenAlex

Drivers and mechanisms of cognitive decline in chronic kidney disease

review Full Text OpenAlex

Improved Alzheimer Disease Diagnosis With a Machine Learning Approach and Neuroimaging: Case Study Development

article Full Text OpenAlex

近5年高被引文献
Alzheimer's disease

review Full Text OpenAlex 3357 FWCI92.943

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 3229 FWCI632.58

2023 Alzheimer's disease facts and figures

article Full Text OpenAlex 2144 FWCI827.821

2022 Alzheimer's disease facts and figures

article Full Text OpenAlex 2031 FWCI419.171

2021 Alzheimer's disease facts and figures

article Full Text OpenAlex 1948 FWCI208.007

Alzheimer disease

review Full Text OpenAlex 1628 FWCI47.401

Donanemab in Early Symptomatic Alzheimer Disease

article Full Text OpenAlex 1340 FWCI396.394

Donanemab in Early Alzheimer’s Disease

article Full Text OpenAlex 1140 FWCI134.716

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

article Full Text OpenAlex 889 FWCI688.332

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease

article Full Text OpenAlex 881 FWCI148.154